MIGAL Research Institute

MIGAL Research Institute

MIGAL Research Institute is a company that provides applied research that is specialized in the fields of biotechnology, environmental and agricultural sciences

MIGAL Research Institute is a company that provides applied research that is specialized in the fields of biotechnology, environmental and agricultural sciences. The company was founded in Kiryat Shmona in 1979.

COVID-19

In response to the outbreak of the COVID-19, MIGAL Research Institute has began developing a vaccine against the novel coronavirus. The company aims to develop the vaccine within weeks and begin production to release within ninety days of development. Their concepts for the vaccine are based on a protein expression vector which creates and secretes a soluble protein which, in turn, delivers the viral antigen into tissues. This should allow the body to form antibodies against the virus. This vaccine is based off of work done for anti-IBV antibodies and the poultry coronavirus. MIGAL Research Institute will provide the vaccine as an oral vaccine to make it more accessible for the public.

The institute is searching for production partners for the manufacturing and distribution of the vaccine.

Timeline

People

Name
Role
LinkedIn

Aviv Elbaz Nudel

Human Resources

Dan Levanon

Scientific Director

David Zigdon

CEO

Libat Malka

CFO

Ruth Shushan

Operation Manager

Snait Tamir

Deputy Scientific Director

Further reading

Title
Author
Link
Type
Date

Home | Migal

Minicy Catom Software Engineering Ltd. www.catom.com

Web

Management & Administration | About | Migal

Minicy Catom Software Engineering Ltd. www.catom.com

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

MIGAL Research Institute

David Zigdon

Kiryat Shmona

Vaccination Institute

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.